WNT5A and gastric cancer: However, Wnt5a, a ligand that usually activates non-canonical Wnt signaling, is also overexpressed in GC patients (Saitoh et al., 2002; Boussioutas et al., 2003; Kurayoshi et al., 2006; Li et al., 2014; Nam et al., 2014).